Two-stage deployment aneurysm embolization devices

US9393022B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9393022-B2
Application numberUS-201313962267-A
CountryUS
Kind codeB2
Filing dateAug 8, 2013
Priority dateFeb 11, 2011
Publication dateJul 19, 2016
Grant dateJul 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embolic implants, delivery systems and methods of manufacture and delivery are disclosed. The subject implants are deployed in two stages. If sized properly as observed in the first stage, they are deployed to the second stage and detached. If not sized properly in/at the first stage, the implants are designed to be withdrawn and replaced with a more appropriately sized implant or another treatment option selected. Some of the implant configurations may be withdrawn even after the second stage deployment as well.

First claim

Opening claim text (preview).

The invention claimed is: 1. An aneurysm treatment system comprising: a catheter with a distal marker and a proximal reference marker; an implant pusher; and an implant connected to a distal end of the implant pusher and comprising a bulbous portion and a tail portion, the tail portion adapted to be received in a linear configuration within the catheter with a distal end of the tail portion being proximal to the bulbous portion when the implant is in an intermediate stage, the tail portion defining an inset within the bulbous portion when the implant is in a final stage, wherein at least one of the pusher and the implant comprises an implant marker, wherein when the implant marker is aligned with the proximal reference marker, the implant is in the intermediate stage with the bulbous portion of the implant deployed from the catheter, wherein, when the implant marker is aligned with the distal marker, the implant is in the final stage with the implant deployed from the catheter and the tail portion defining the inset within the bulbous portion, wherein the implant has a height that is approximately the same in the intermediate stage and in the final stage. 2. The system of claim 1 , wherein the bulbous portion has a teardrop shape in the intermediate stage. 3. The system of claim 1 , wherein the bulbous portion has a mushroom shape in the intermediate stage. 4. The system of claim 1 , wherein the inset is configured to be recapturable in clinical use. 5. The system of claim 1 , wherein the inset is configured so that it is not recapturable in clinical use. 6. The system of claim 5 , wherein the inset is substantially spherical. 7. The system of claim 5 , wherein the inset has an opposing cone shape. 8. The system of claim 5 , wherein the inset includes an inverted hub. 9. The system of claim 5 , wherein the inset includes no hub. 10. The system of claim 9 , wherein the inset is adapted to expand from a compressed conical shape. 11. The system of claim 10 , wherein the inset is adapted to expand into the bulbous portion.

Assignees

Inventors

Classifications

  • Details concerning the detachment of the occluding device from the introduction device · CPC title

  • Solid plugs; being solid before insertion · CPC title

  • Methods of manufacturing · CPC title

  • having a pre-set deployed three-dimensional shape (methods of manufacturing A61B2017/00526) · CPC title

  • shape memory effect · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9393022B2 cover?
Embolic implants, delivery systems and methods of manufacture and delivery are disclosed. The subject implants are deployed in two stages. If sized properly as observed in the first stage, they are deployed to the second stage and detached. If not sized properly in/at the first stage, the implants are designed to be withdrawn and replaced with a more appropriately sized implant or another treat…
Who is the assignee on this patent?
Covidien Lp
What technology area does this patent fall under?
Primary CPC classification A61B17/12159. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).